ACCESS: Prevention and Treatment of Malaria in Africa
In sub-Saharan Africa, malaria infection is estimated to cause 400,000 cases of severe maternal anemia and 75,000-200,000 infant deaths annually. Maternal anemia contributes significantly to maternal mortality and causes an estimated 10,000 deaths per year. In areas of stable transmission, the WHO promotes a three-prong strategy to address MIP prevention and control: 1) intermittent preventive treatment during pregnancy (IPTp); 2) insecticide treated nets (ITNs) for prevention; and 3) case management for treatment.
ACCESS supports the prevention and treatment of malaria in Africa, with an emphasis on malaria in pregnancy (MIP). From 2004-2006, ACCESS was one of four partners—with the Centers for Disease Control and Prevention, World Health Organization (WHO) and Rational Pharmaceutical Management Plus—of the USAID-funded Malaria Action Coalition (MAC). The MAC collectively provided technical support to countries to address the burden of malaria for both prevention and treatment.
Most notably during this partnership, ACCESS served as Secretariat to the Roll Back Malaria, Malaria in Pregnancy Working Group, which included contributing to the development of global consensus statements to support MIP program implementation. At the regional level, ACCESS supported regional MIP coalitions and the sub-regional RBM networks to promote the exchange of information and best practices, development of regional capacity, and revision of national MIP policies. At the country level, ACCESS supported program implementation in six African countries—Burkina Faso, Kenya, Madagascar, Mali, Rwanda, Uganda—with the goal of improving malaria prevention and treatment services provided to pregnant women during antenatal care.
ACCESS continues to provide technical guidance on malaria through the development of clinical and programmatic materials, revising its MIP clinical training materials to reflect the most up-to-date information and current guidance from the WHO. ACCESS has also collaborated with the Centers for Disease Control and Prevention, the Rational Pharmaceutical Management Plus Program/MSH and WHO to develop a MIP program implementation guide for the African region.
To further apply its MIP clinical and programmatic expertise, ACCESS assists African countries develop proposals for funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). GFATM grants provide an important support to allow countries to sustain and grow their malaria prevention and control programs. Moreover, for those countries with existing GFATM grants that have experienced problems implementing their programs, ACCESS helps to identify bottlenecks and devise solutions to overcome them.
The ACCESS Program is the U.S. Agency for International Development''s global program to improve maternal and newborn health. The ACCESS Program works to expand coverage, access and use of key maternal and newborn health services across a continuum of care from the household to the hospital—with the aim of making quality health services accessible for women and newborns. Jhpiego implements the program in partnership with Save the Children, Constella Futures, the Academy for Educational Development, the American College of Nurse-Midwives and Interchurch Medical Assistance.
- Ouagadougou, Burkina Faso: 11 projects
- Yaounde, Cameroon: 6 projects
- Nairobi, Kenya: 34 projects
- Antananarivo, Madagascar: 4 projects
- Bamako, Mali: 20 projects - selected city
- Nouakchott, Mauritania: 2 projects
- Niamey, Niger : 8 projects
- Kigali, Rwanda: 6 projects
- Lome, Togo: 3 projects
- Kampala, Uganda: 72 projects